{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:23Z","timestamp":1789773443966,"version":"4.0.1"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Illumina, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Genome-wide prenatal cell-free DNA (cfDNA) screening can be used to screen for a wide range of fetal chromosomal anomalies in pregnant patients. In this study, we describe our clinical experience with a genome-wide cfDNA assay in screening for common trisomies, sex chromosomal aneuploidies (SCAs), rare autosomal aneuploidies (RAAs), and copy-number variations (CNVs) in about 6000 patients over a three-year period at our hospital\u2019s Prenatal Diagnostic Unit in Spain. Overall, 204 (3.3%) patients had a high-risk call, which included 76 trisomy 21, 21 trisomy 18, 7 trisomy 13, 29 SCAs, 31 RAAs, 31 CNVs, and 9 cases with multiple anomalies. The diagnostic outcomes were obtained for the high-risk cases when available, allowing for the calculation of positive predictive values (PPVs). Calculated PPVs were 95.9% for trisomy 21, 77.8% for trisomy 18, 66.7% for trisomy 13, 10.7% for RAAs, and 10.7% for CNVs. Pregnancy and birth outcomes were also collected for the majority of RAA and CNV cases. Adverse perinatal outcomes for some of these cases included preeclampsia, fetal growth restriction, preterm birth, reduced birth weight, and major congenital structural abnormalities. In conclusion, our study showed strong performance for genome-wide cfDNA screening in a large cohort of pregnancy patients in Spain.<\/jats:p>","DOI":"10.3390\/genes15050568","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T10:33:31Z","timestamp":1714559611000},"page":"568","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prenatal Genome-Wide Cell-Free DNA Screening: Three Years of Clinical Experience in a Hospital Prenatal Diagnostic Unit in Spain"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3031-6124","authenticated-orcid":false,"given":"Laia","family":"Pedrola Vidal","sequence":"first","affiliation":[{"name":"Genetics Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Rosell\u00f3 Piera","sequence":"additional","affiliation":[{"name":"Genetics Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0442-819X","authenticated-orcid":false,"given":"Carla","family":"Mart\u00edn-Grau","sequence":"additional","affiliation":[{"name":"Translational Genetics Research Group, Instituto de Investigaci\u00f3n Sanitaria La Fe (IISLAFE), 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan S.","family":"Rubio Moll","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"G\u00f3mez Portero","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Marcos Puig","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-1106","authenticated-orcid":false,"given":"Jose V.","family":"Cervera Zamora","sequence":"additional","affiliation":[{"name":"Genetics Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Quiroga","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Orellana Alonso","sequence":"additional","affiliation":[{"name":"Genetics Unit, Hospital Universitari i Polit\u00e8cnic La Fe, 46026 Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jogc.2017.01.032","article-title":"No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes","volume":"39","author":"Audibert","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/ejhg.2015.57","article-title":"Non-invasive prenatal testing for aneuploidy and beyond: Challenges of responsible innovation in prenatal screening","volume":"23","author":"Dondorp","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100336","DOI":"10.1016\/j.gim.2022.11.004","article-title":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Dungan","year":"2023","journal-title":"Genet. Med."},{"key":"ref_4","first-page":"1","article-title":"Decalogue of the lc-DNA test in maternal blood for prenatal diagnosis (2020)","volume":"63","year":"2020","journal-title":"Prog. Obstet. Ginecol. (Ed. Impr.)"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pd.6357","article-title":"Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies","volume":"43","author":"Hui","year":"2023","journal-title":"Prenat. Diagn."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/AOG.0000000000004107","article-title":"Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226","volume":"136","author":"Rose","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ejhg.2011.246","article-title":"Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe","volume":"20","author":"Wellesley","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Harasim, T., Neuhann, T., Behnecke, A., Stampfer, M., Holinski-Feder, E., and Abicht, A. (2022). Initial Clinical Experience with NIPT for Rare Autosomal Aneuploidies and Large Copy Number Variations. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020372"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"975987","DOI":"10.3389\/fgene.2022.975987","article-title":"Multisite assessment of the impact of cell-free DNA-based screening for rare autosomal aneuploidies on pregnancy management and outcomes","volume":"13","author":"Mossfield","year":"2022","journal-title":"Front. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/clinchem\/hvab067","article-title":"Performance of a Paired-End Sequencing-Based Noninvasive Prenatal Screening Test in the Detection of Genome-Wide Fetal Chromosomal Anomalies","volume":"67","author":"Pertile","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/gim.2016.72","article-title":"Cell-free DNA testing of an extended range of chromosomal anomalies: Clinical experience with 6,388 consecutive cases","volume":"19","author":"Pescia","year":"2017","journal-title":"Genet. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/s41436-021-01227-5","article-title":"Genome-wide cell-free DNA screening: A focus on copy-number variants","volume":"23","author":"Rafalko","year":"2021","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/s41436-021-01135-8","article-title":"Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants","volume":"23","author":"Soster","year":"2021","journal-title":"Genet. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41436-021-01101-4","article-title":"Outcome of publicly funded nationwide first-tier noninvasive prenatal screening","volume":"23","author":"Lannoo","year":"2021","journal-title":"Genet. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","article-title":"Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study","volume":"109","author":"Sistermans","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_16","unstructured":"Illumina, I. (2021, February 05). VeriSeq NIPT Solution v2 Package Insert. Available online: https:\/\/support.illumina.com\/content\/dam\/illumina-support\/documents\/documentation\/chemistry_documentation\/veriseq-nipt-v2\/1000000078751_08_veriseq-nipt-solution-v2-package-insert.pdf."},{"key":"ref_17","unstructured":"Illumina, I. (2021, February 05). VeriSeq NIPT Solution v2 Software Guide. Available online: https:\/\/emea.support.illumina.com\/content\/dam\/illumina-support\/documents\/documentation\/chemistry_documentation\/veriseq-nipt-v2\/1000000067940_08_veriseq-nipt-solution-v2-software-guide-IVD.pdf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands","volume":"105","author":"Sistermans","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3390\/jcm3030809","article-title":"Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis","volume":"3","author":"Grati","year":"2014","journal-title":"J. Clin. Med."},{"key":"ref_20","unstructured":"Page-Christiaens, L., and Klein, H.-G. (2018). Noninvasive Prenatal Testing (NIPT): Applied Genomics in Prenatal Screening and Diagnosis, Elsevier\/Academic Press."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000098184","article-title":"X chromosome loss and ageing","volume":"116","author":"Russell","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/pd.5325","article-title":"Rare autosomal trisomies: Important and not so rare","volume":"38","author":"Scott","year":"2018","journal-title":"Prenat. Diagn."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/gim.2017.132","article-title":"Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: Results of the TRIDENT study","volume":"20","author":"Lichtenbelt","year":"2018","journal-title":"Genet. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"eaan1240","DOI":"10.1126\/scitranslmed.aan1240","article-title":"Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease","volume":"9","author":"Pertile","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_26","first-page":"867","article-title":"Recombination and maternal age-dependent nondisjunction: Molecular studies of trisomy 16","volume":"57","author":"Hassold","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ajog.2022.08.034","article-title":"The predictive value of prenatal cell-free DNA testing for rare autosomal trisomies: A systematic review and meta-analysis","volume":"228","author":"Acreman","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/humupd\/dmab009","article-title":"Confined placental mosaicism and the association with pregnancy outcome and fetal growth: A review of the literature","volume":"27","author":"Eggenhuizen","year":"2021","journal-title":"Hum. Reprod. Update"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/pd.6233","article-title":"Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances","volume":"42","author":"Raymond","year":"2022","journal-title":"Prenat. Diagn."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/gim.2018.32","article-title":"Mosaic maternal 10qter deletions are associated with FRA10B expansions and may cause false-positive noninvasive prenatal screening results","volume":"20","author":"Straver","year":"2018","journal-title":"Genet. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive Prenatal Test Results Indicative of Maternal Malignancies: A Nationwide Genetic and Clinical Follow-Up Study","volume":"40","author":"Heesterbeek","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.gendis.2023.04.008","article-title":"Non-invasive prenatal testing can detect silent cancers in expecting mothers","volume":"11","author":"Ottaiano","year":"2024","journal-title":"Genes Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: A position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/5\/568\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:35:26Z","timestamp":1760106926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/5\/568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["genes15050568"],"URL":"https:\/\/doi.org\/10.3390\/genes15050568","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,28]]}}}